A careful evaluation of the therapeutic choice is necessary in every phase of diabetes progression
National and international diabetes guidelines recommend achieving a target value of glycated hemoglobin value that is dependent upon various factors including patient age, disease duration, co-morbidities, life expectancy and socio-economic conditions. The drug of choice is usually metformin, whic...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AboutScience Srl
2018-09-01
|
| Series: | AboutOpen |
| Subjects: | |
| Online Access: | https://journals.aboutscience.eu/index.php/aboutopen/article/view/141 |